RxDoctor Payments Data

Gal Andres, MD

Psychiatry · Ontario, CANPI 1043779903

Payments from drug & device makers

$859in general payments, 2019–2025

Across 31 payments — averaging $27.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$256
  • Alkermes, Inc.$167
  • H2-pharma, LLC$150
  • Johnson & Johnson$76
  • Otsuka America Pharmaceutical, Inc.$74
  • E.r. Squibb & Sons, L.L.C.$57
  • plus $80 from 3 others

What the payments were for

  • Speaking & faculty fees$15017%
  • Food & beverage$59569%
  • Education$11413%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$859 in reported general payments places this provider in the 70th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$11,049
Medicare patients
25
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate20$66,536
LybalviOlanzapine/Samidorphan Malate12$18,612
Aripiprazole OdtAripiprazole12$7,719
Aripiprazole30$1,556
Haloperidol Decanoate32$886
Olanzapine42$783
Hydroxyzine Hcl41$780
Doxepin Hcl12$645
Trazodone Hcl66$537
Risperidone60$473
Duloxetine Hcl24$404
Prazosin Hcl25$362
Benztropine Mesylate36$246
Bupropion XlBupropion Hcl16$229
Buspirone Hcl12$222

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$76$66,53620 claims
Alkermes, Inc.Lybalvi$167$18,61212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Ontario

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →